Harsha Thirumurthy of the Perelman School of Medicine said vaccine patents keep prices artificially high by limiting other countries’ ability to manufacture vaccines. “I think we had the best hope of it last year when there was a proposal that was put forward at the WTO and the Biden administration had supported it,” he said. “But we had European countries that objected to those patent waivers.”
https://www.cnbc.com/2022/01/22/why-moderna-pfizer-and-the-nih-debate-who-owns-the-covid-vaccine.html CNBC